Clinical Trial Update: Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two doses of psilocybin for major depressive disorder in adults with cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Sunstone Medical | Conditions: Cancer, Major Depressive Disorder | Phase 2 | Status: RECRUITING